Effect of Disulfiram on Canine Liver Aldehyde Dehydrogenase Activity: In Vivo Inactivation in a Nonrodent Animal Model

Charles Sanny, Andrew J. Mahoney, Mearl A. Kilmore, Kimberlee Rymas

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Dogs were used as nonrodent animal models to study the in vivo effects of disulfiram on hepatic aldehyde dehydrogenase (ALDH) activity. Dogs were treated with disulfiram either intraperitoneally or orally (100 mg/kg/day for 2 days followed by 40 mg/kg/day for 3 days). Liver biopsies from control and treated animals were fractionated by differential centrifugation and the subcellular fractions were analyzed for ALDH activity. Significantly less activity was observed in cell homogenates from treated animals (20–50% of control activity per gram of liver). The majority of loss in activity was accounted for by a decrease in ALDH activity in the soluble fraction of the cell (12–30% of control activity) and in the mitochondrial fraction (23–30% of control activity). Activities at both high (5 mM) and low (50 μM) acetaldehyde concentrations were affected. The subcellular distribution of ALDH activity and in vivo inhibition by disulfiram in dogs is different from that reported for rats.

Original languageEnglish
Pages (from-to)622-624
Number of pages3
JournalAlcoholism: Clinical and Experimental Research
Volume12
Issue number5
DOIs
StatePublished - 1 Jan 1988

Fingerprint

Disulfiram
Aldehyde Dehydrogenase
Liver
Canidae
Animals
Animal Models
Dogs
Subcellular Fractions
Acetaldehyde
Centrifugation
Biopsy
Rats

Cite this

@article{9ffc60d9461e4831bf798b314b13b50b,
title = "Effect of Disulfiram on Canine Liver Aldehyde Dehydrogenase Activity: In Vivo Inactivation in a Nonrodent Animal Model",
abstract = "Dogs were used as nonrodent animal models to study the in vivo effects of disulfiram on hepatic aldehyde dehydrogenase (ALDH) activity. Dogs were treated with disulfiram either intraperitoneally or orally (100 mg/kg/day for 2 days followed by 40 mg/kg/day for 3 days). Liver biopsies from control and treated animals were fractionated by differential centrifugation and the subcellular fractions were analyzed for ALDH activity. Significantly less activity was observed in cell homogenates from treated animals (20–50{\%} of control activity per gram of liver). The majority of loss in activity was accounted for by a decrease in ALDH activity in the soluble fraction of the cell (12–30{\%} of control activity) and in the mitochondrial fraction (23–30{\%} of control activity). Activities at both high (5 mM) and low (50 μM) acetaldehyde concentrations were affected. The subcellular distribution of ALDH activity and in vivo inhibition by disulfiram in dogs is different from that reported for rats.",
author = "Charles Sanny and Mahoney, {Andrew J.} and Kilmore, {Mearl A.} and Kimberlee Rymas",
year = "1988",
month = "1",
day = "1",
doi = "10.1111/j.1530-0277.1988.tb00253.x",
language = "English",
volume = "12",
pages = "622--624",
journal = "Alcoholism: Clinical and Experimental Research",
issn = "0145-6008",
publisher = "Wiley-Blackwell",
number = "5",

}

Effect of Disulfiram on Canine Liver Aldehyde Dehydrogenase Activity : In Vivo Inactivation in a Nonrodent Animal Model. / Sanny, Charles; Mahoney, Andrew J.; Kilmore, Mearl A.; Rymas, Kimberlee.

In: Alcoholism: Clinical and Experimental Research, Vol. 12, No. 5, 01.01.1988, p. 622-624.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of Disulfiram on Canine Liver Aldehyde Dehydrogenase Activity

T2 - In Vivo Inactivation in a Nonrodent Animal Model

AU - Sanny, Charles

AU - Mahoney, Andrew J.

AU - Kilmore, Mearl A.

AU - Rymas, Kimberlee

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Dogs were used as nonrodent animal models to study the in vivo effects of disulfiram on hepatic aldehyde dehydrogenase (ALDH) activity. Dogs were treated with disulfiram either intraperitoneally or orally (100 mg/kg/day for 2 days followed by 40 mg/kg/day for 3 days). Liver biopsies from control and treated animals were fractionated by differential centrifugation and the subcellular fractions were analyzed for ALDH activity. Significantly less activity was observed in cell homogenates from treated animals (20–50% of control activity per gram of liver). The majority of loss in activity was accounted for by a decrease in ALDH activity in the soluble fraction of the cell (12–30% of control activity) and in the mitochondrial fraction (23–30% of control activity). Activities at both high (5 mM) and low (50 μM) acetaldehyde concentrations were affected. The subcellular distribution of ALDH activity and in vivo inhibition by disulfiram in dogs is different from that reported for rats.

AB - Dogs were used as nonrodent animal models to study the in vivo effects of disulfiram on hepatic aldehyde dehydrogenase (ALDH) activity. Dogs were treated with disulfiram either intraperitoneally or orally (100 mg/kg/day for 2 days followed by 40 mg/kg/day for 3 days). Liver biopsies from control and treated animals were fractionated by differential centrifugation and the subcellular fractions were analyzed for ALDH activity. Significantly less activity was observed in cell homogenates from treated animals (20–50% of control activity per gram of liver). The majority of loss in activity was accounted for by a decrease in ALDH activity in the soluble fraction of the cell (12–30% of control activity) and in the mitochondrial fraction (23–30% of control activity). Activities at both high (5 mM) and low (50 μM) acetaldehyde concentrations were affected. The subcellular distribution of ALDH activity and in vivo inhibition by disulfiram in dogs is different from that reported for rats.

UR - http://www.scopus.com/inward/record.url?scp=0024211947&partnerID=8YFLogxK

U2 - 10.1111/j.1530-0277.1988.tb00253.x

DO - 10.1111/j.1530-0277.1988.tb00253.x

M3 - Article

C2 - 3067604

AN - SCOPUS:0024211947

VL - 12

SP - 622

EP - 624

JO - Alcoholism: Clinical and Experimental Research

JF - Alcoholism: Clinical and Experimental Research

SN - 0145-6008

IS - 5

ER -